Aurous healthcare

MD Message

Dear Colleagues !

Greetings…

Research and experimental development is creative work undertaken systematically to increase the stock of knowledge which is used to establish or confirm facts and to reaffirm the results of previous works for solving new or existing problems to support theorems or to develop new theories. Clinical research is the most aspired field of the era blooming into discovering drugs and estimating their efficacy and safety by the research professionals.

I am delighted to share with you that Aurous healthcare Research & Development India Private Limited have unleashed a plethora of scientific initiatives developing excellence starting from 2008 commencing as an Independent contract research organization and expanding ourselves into healthcare and academic domains ensuring quality in everything we deliver. As an organization AHC has been realizing stronger growth than the market by providing quality oriented solutions for pharmaceutical companies without compromising business ethics. While essentially acting with reference to the company’s mission, vision, values and code of business principle, we have set our sight higher and all geared up to make AHC evolve brick by brick which is vibrant & stronger from within, powering execution with commitment & professionalism, creating an empowered motivated team for accelerating growth in research & development generating confidence of brighter future and better place to work and to deliver results for the benefit of mankind while contributing towards a healthier world.

To achieve ambitious goals, to be innovative, to decide and act, to appreciate & encourage team work and to recognize results we have empowered with an expertise team which adheres to the principle of “Safety assured to the subjects involved in the clinical trials” and in conducting our work with utmost sincerity.

At last I would like to say that we began this company with nothing much more than a pocket full of dreams and it still takes me by surprise to see how far we have travelled.Because we dream big and we are not afraid to try out even seemingly impossible ideas, we strive to make a mark in every field that we enter.

Quality wins…..!

Warm wishes

Dr.V.T.Sriraam

Managing Director

News

News

  • Article in The Hindu - BUSINESS LINE (March 10, 2014; Pg 18) detailing about R & D partnership of Aurous Healthcare for one of our primordial client- Dhathri Group Readmore..
  • “Article in Deccan Chronicle Chennai (04-Aug-13 Pg26) on the health benefits of Collagen Peptide by Dr. VT.Sriraam” Download Article

  • Public awareness article written by our Managing Director Dr. V. T. Sriraam, M.B.B.S, M.D. published in Tamil Daily "Thinathanthi" on 03-Feb-13. Download Article

  • We are awarded as “The most promising Healthcare R&D Company from Chennai, Tamil Nadu” by BIG research, a brand finding organization from Delhi with its media PartnerNDTV Profit.
    You tube Link: http://youtu.be/eMW1VeSzp2M

  • For the first time in the arena of Clinical Research Academy of India, our academic division “Auro Academy of Education and Research” launches a course in clinical research “Fellowship in Clinical Research Management” with 100% Job Guarantee (14 months work experience as CRA/CRC in our CRO).
    Link: http://auroushealthcare.com/pdf/AAER%20BROCHURE.pdf

  • We have set records in successful completion of two phase III trials on Osteoarthritis on collagen peptide, undertaken from an Indo Japan client and the product Gelixer has got launched successfully into the market
    Link: :http://www.gelixer.com/medical_professionals.asp http://www.youtube.com/watch?feature=player_embedded&v=YoybGsbsQno#!

  • Undertaking of a drug discovery and drug development – End to End project: We have successfully completed formulation and development and animal studies of a FDC (Fixed dose combination) project in Ophthalmology for an Indo MNC. Clinical trial is to be commenced shortly.

  • Ongoing clinical trial projects:
    • Phase III b trial on Osteoporosis
    • Phase III b trial on Dysmennorrhea
    • Dermatological trial on coloring agents
    • 6 Phase IV trials on herbal cosmeceuticals

  • We have completed a two animal toxicity study for FDC (fixed dose combination) in ophthalmology.

  • We have successfully completed the 2nd Surveillance Audit for ISO 9001:2008 certification for Quality Management System.

  • Our Medical Director, DR. V.T. Sriraam, M.D (Pharmacology), has presented a topic in 2011 International Conference on Food Factors on RCT to prove effectiveness and safety of Colla Pep JP and Colla Pep PU dated Nov 20-23, 2011, Taiwan.
    Link :http://www.icoff2011.org/SponsorSessionSpeakers.html

  • Presently, we are undertaking 12 end to end clinical trial managementing various therapeutic areas for Indian, Malaysian and Japanese based MNC.

Our Services

Embroidered Devil Eyes
Spring Embroidery
Geometrical Embroidery
Elephant with Luck
Lady in Red
Fireworks Embroidery Art
Fireworks Embroidery Art

Vision and Mission

Vision
To become the world’s premier quality driven organization in the field of clinical research..Readmore

News and Downloads

Article in Deccan Chronicle Chennai (04-Aug-13 Pg26) on the health benefits..Readmore

Accreditation

ISO Certificate
We have successfully completed the2nd Surveillance Audit for ISO 9001:2008Download

Corporate Profile

No matter what the scope of the activity, our approach remains consistent. Quality Wins!..Download